BrookmeyerRAbdallaN. Design and sample size considerations for Alzheimer’s disease prevention using multistate models. Clin Trials, in press.
2.
Steering Committee of the Physicians Health Study Research Group. Final report on the aspirin component of the ongoing physicians’ health study. N Engl J Med1989; 321(3): 129–135.
3.
MeldrumM.A ‘calculated risk’: the Salk polio vaccine field trials of 1954. BMJ1998; 317(7167): 1233–1236.
4.
CummingsJLDoodyRClarkC.Disease-modifying therapies for Alzheimer disease challenges to early intervention. Neurology2007; 69(16): 1622–1634.
5.
BenatarMWuuJ.Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology2012; 79(16): 1732–1739.
